
Mindshare Medical, now operating as RevealDx, is a healthcare technology company focused on precision medicine through image-driven intelligence. They have developed a clinical decision support technology that provides personalized diagnostics and guidance on treatment effectiveness, aiming to improve patient care and reduce financial liability for healthcare organizations. Their solution, RevealAI™, uses computer-assisted diagnostics and machine learning on medical images to detect patterns difficult for humans to discern, generating actionable scores and novel biomarkers. RevealAI-Lung specifically addresses lung nodule management by providing a Malignancy Similarity Index (mSI) from CT scans to aid risk assessment and reduce false positives and the time to diagnosis. The company has obtained CE Mark and Health Canada medical device licenses for RevealAI-Lung.

Mindshare Medical, now operating as RevealDx, is a healthcare technology company focused on precision medicine through image-driven intelligence. They have developed a clinical decision support technology that provides personalized diagnostics and guidance on treatment effectiveness, aiming to improve patient care and reduce financial liability for healthcare organizations. Their solution, RevealAI™, uses computer-assisted diagnostics and machine learning on medical images to detect patterns difficult for humans to discern, generating actionable scores and novel biomarkers. RevealAI-Lung specifically addresses lung nodule management by providing a Malignancy Similarity Index (mSI) from CT scans to aid risk assessment and reduce false positives and the time to diagnosis. The company has obtained CE Mark and Health Canada medical device licenses for RevealAI-Lung.